Matorras et al., 2001 - Google Patents
Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosisMatorras et al., 2001
View HTML- Document ID
- 18151805686160757474
- Author
- Matorras R
- Rodrı́guez F
- Pijoan J
- Etxanojauregui A
- Neyro J
- Elorriaga M
- Rodrı́guez-Escudero F
- Publication year
- Publication venue
- Fertility and sterility
External Links
Snippet
Objective: To compare the prevalence of endometriosis and its different stages in infertile women and women not exposed to spermatozoa. Design: Prospective study. Setting: Artificial insemination donor program at a university hospital. Patient (s): One hundred fifty …
- 201000009273 endometriosis 0 title abstract description 107
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arcoverde et al. | Surgery for endometriosis improves major domains of quality of life: a systematic review and meta-analysis | |
| Sheikh et al. | Evaluation of compliance and outcomes of a management protocol for massive postpartum hemorrhage at a tertiary care hospital in Pakistan | |
| Shigemi et al. | Safety of laparoscopic surgery for benign diseases during pregnancy: a nationwide retrospective cohort study | |
| Matorras et al. | Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis | |
| Harada et al. | Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial | |
| Abbott et al. | A double-blind randomized trial comparing the Cavaterm™ and the NovaSure™ endometrial ablation systems for the treatment of dysfunctional uterine bleeding | |
| Amir et al. | Ovarian stimulation outcomes among transgender men compared with fertile cisgender women | |
| Matteson et al. | Menstrual health as a part of preventive health care | |
| Comptour et al. | Patient quality of life and symptoms after surgical treatment for endometriosis | |
| Narayan et al. | Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison | |
| Cui et al. | Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study | |
| Mendoza et al. | Position of the Spanish Menopause Society regarding the management of perimenopause | |
| Matorras et al. | Endometriosis and spontaneous abortion rate: a cohort study in infertile women | |
| Alborzi et al. | Surgical outcomes of laparoscopic endometriosis surgery: a 6 year experience | |
| Zhao et al. | Logistic regression analyses of factors affecting fertility of intrauterine adhesions patients | |
| Gilbert et al. | Direct methotrexate injection into the gestational sac for nontubal ectopic pregnancy: a review of efficacy and outcomes from a single institution | |
| Munro et al. | Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process | |
| Kim et al. | The trend, feasibility, and safety of salpingectomy as a form of permanent sterilization | |
| Gunes et al. | The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study | |
| Naessen et al. | Endometrial thickness and uterine diameter not affected by ultralow doses of 17β-estradiol in elderly women | |
| Yu et al. | Clinical and patient reported outcomes of pre-and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy | |
| Hatırnaz et al. | Vaginal ultrasound-guided ovarian needle puncture compared to laparoscopic ovarian drilling in women with polycystic ovary syndrome | |
| Bansal et al. | Diagnosing the acutely locked knee | |
| Sullivan et al. | Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complications | |
| Matorras et al. | Fertility in women with minimal endometriosis compared with normal women was assessed by means of a donor insemination program in unstimulated cycles |